Skip to main content

Alignment Healthcare Inc

For the period ended Dec 31, 2023. Filed Feb 27, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 27, 2024

ALHC$7.27-1.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 9B. Other Information

On February 22, 2024, the Board approved amendments to the Company’s Bylaws and readopted them in full (as amended and restated, the “Bylaws”), effective immediately, to update certain procedural requirements related to director nominations and to incorporate other changes as well as ministerial, clarifying and conforming edits. Changes to the Bylaws include, among other things, (i) providing for additional means of adjourning a stockholder meeting to another time and place without notice; (ii) requiring that a stockholder soliciting proxies from other stockholders use a proxy card color other than white, which shall be reserved for exclusive use by the Board; (iii) removing the requirement for the Company to produce and keep for examination by any stockholder at the time and place of a meeting of stockholders a complete list of the stockholders entitled to vote at such meeting, which conform to amendments to the Delaware General Corporation Law; and (iv) adding a requiring that stockholders proposing business or director nominations at a stockholders meeting provide a representation that each stockholder shall provide all information, affirmations, updates and supplements required by Article II of the Bylaws, and revising applicable language to give the Company the ability to request additional information from such stockholders. The foregoing description of the amendments to the Bylaws is qualified in its entirety by reference to the full text of the Bylaws filed as Exhibit 3.2 to this Annual Report.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.